4 papers in the library · publishing 2025-2026
L'Encephale June 1, 2026 Alix Romier, Jeanne Leseur, Anne Moroy et al.
Suicidal behaviors-including suicidal ideation, suicide attempts, and suicide deaths-represent a major global health concern. Identifying proximal, modifiable risk factors is crucial to improve early detection and prevention. Sleep disturbances have emerged as proximal and modifiable risk factor for suicide, yet their role is often underestimated in clinical practice. This chapter synthesizes...
medRxiv Preprint Server April 23, 2026 Willys Cantenys, Zeynep Yoldas, Luc Masset et al. preprint
Background Ketamine is a rapid-acting antidepressant that produces acute dissociative symptoms. In routine care, the respective contributions of therapeutic expectations and dissociative symptoms to antidepressant response, and the directionality of their associations with depressive symptom change, remain poorly characterized.
bioRxiv (Cold Spring Harbor Laboratory) September 1, 2025 Jean-Baptiste Maranci, Pierre Champetier, Delphine Oudiette et al. preprint
Abstract Sleep helps regulate emotions, but it is still unclear whether -and how- the emotions we experience in dreams contribute to this regulation. To uncover the potential function of dream emotions, we must first understand what they are and how they unfold in dreams. The emotional content of dreams has mostly been studied using post-sleep dream reports, which provide a biased and static...
Zeynep Yoldas, Willys Cantenys, Morgane Tronche et al. preprint
Background: Facial emotion recognition deficits are well defined in depression but understudied in treatment-resistant depression (TRD). Over the past decades, subanesthetic doses of ketamine have emerged as an effective treatment for TRD, but its effect on affective processing is still little known. Approaches from computational psychiatry, such as sequential evidence sampling models of...